{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1380011143985330179.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Yukihiko Kawasaki"}],"foaf:familyName":[{"@value":"Kawasaki"}],"foaf:givenName":[{"@value":"Yukihiko"}]}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360011143985330176","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1007/s10067-010-1484-5"},{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1007/s10067-010-1484-5.pdf"},{"@type":"URI","@value":"http://link.springer.com/article/10.1007/s10067-010-1484-5/fulltext.html"},{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1007/s10067-010-1484-5"},{"@type":"PMID","@value":"20490589"}],"notation":[{"@value":"Mizoribine attenuates renal injury and macrophage infiltration in patients with severe lupus nephritis"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1007/s10067-010-1484-5_5kWbmlDQtYptrc3A2IhXYsPhZL"},{"@type":"OPENAIRE","@value":"doi_dedup___::e66d66e958fbdbdaec23a0110837847a_5kWbmlDQtYptrc3A2IhXYsPhZL"}]}